| Dr Kenneth A Hermens, MD | |
|
1200 Ne 48th Ave, Ste 1100, Hillsboro, OR 97124-5062 | |
| (503) 844-8310 | |
| Not Available |
| Full Name | Dr Kenneth A Hermens |
|---|---|
| Gender | Male |
| Speciality | Orthopaedic Surgery |
| Location | 1200 Ne 48th Ave, Hillsboro, Oregon |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861560245 | NPI | - | NPPES |
| 121582 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | MD12217 (Oregon) | Primary |
| Entity Name | Tuality Healthcare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275591984 PECOS PAC ID: 3678486107 Enrollment ID: O20040130000359 |
News Archive
According to a major Finnish-Norwegian study, the previously reported association of obesity with a lower risk of subarachnoid hemorrhage appears to be primarily explained by people's smoking habits.
QPharma, Inc. has announced the launch of its Compliance Advantage solution, a set of tools and methodologies to streamline compliance and validation activities for life science companies implementing enterprise application systems.
Despite important progress in research and development (R&D) for global health over the past decade, only a small fraction of new medicines developed between 2000 and 2011 were for the treatment of neglected diseases, highlighting the 'fatal imbalance' between global disease burden and drug development for some of the world most devastating illnesses, said Doctors Without Borders/M-decins Sans Fronti-res (MSF) and the Drugs for Neglected Diseases initiative (DNDi), in an analysis to be presented today at an international conference aimed at spurring medical innovations for these diseases.
A study conducted by researchers at Thomas Jefferson University, Philadelphia, and published Tuesday, July 27, 2004, in the journal Neurology, shows that Frova (frovatriptan), a triptan class migraine therapy with a long half life, significantly reduced the incidence of menstrual associated migraines (MAM) in women who took the medication preventively, in advance of anticipated onset of headache.
Researchers at University of California, San Diego School of Medicine have identified a control mechanism for an area of the brain that processes sensory and emotive information that humans experience as "disappointment."
› Verified 5 days ago
| Entity Name | Tuality Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073929782 PECOS PAC ID: 7416173414 Enrollment ID: O20140729000238 |
News Archive
According to a major Finnish-Norwegian study, the previously reported association of obesity with a lower risk of subarachnoid hemorrhage appears to be primarily explained by people's smoking habits.
QPharma, Inc. has announced the launch of its Compliance Advantage solution, a set of tools and methodologies to streamline compliance and validation activities for life science companies implementing enterprise application systems.
Despite important progress in research and development (R&D) for global health over the past decade, only a small fraction of new medicines developed between 2000 and 2011 were for the treatment of neglected diseases, highlighting the 'fatal imbalance' between global disease burden and drug development for some of the world most devastating illnesses, said Doctors Without Borders/M-decins Sans Fronti-res (MSF) and the Drugs for Neglected Diseases initiative (DNDi), in an analysis to be presented today at an international conference aimed at spurring medical innovations for these diseases.
A study conducted by researchers at Thomas Jefferson University, Philadelphia, and published Tuesday, July 27, 2004, in the journal Neurology, shows that Frova (frovatriptan), a triptan class migraine therapy with a long half life, significantly reduced the incidence of menstrual associated migraines (MAM) in women who took the medication preventively, in advance of anticipated onset of headache.
Researchers at University of California, San Diego School of Medicine have identified a control mechanism for an area of the brain that processes sensory and emotive information that humans experience as "disappointment."
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kenneth A Hermens, MD 1200 Ne 48th Ave, Ste 1100, Hillsboro, OR 97124-5062 Ph: (503) 844-8310 | Dr Kenneth A Hermens, MD 1200 Ne 48th Ave, Ste 1100, Hillsboro, OR 97124-5062 Ph: (503) 844-8310 |
News Archive
According to a major Finnish-Norwegian study, the previously reported association of obesity with a lower risk of subarachnoid hemorrhage appears to be primarily explained by people's smoking habits.
QPharma, Inc. has announced the launch of its Compliance Advantage solution, a set of tools and methodologies to streamline compliance and validation activities for life science companies implementing enterprise application systems.
Despite important progress in research and development (R&D) for global health over the past decade, only a small fraction of new medicines developed between 2000 and 2011 were for the treatment of neglected diseases, highlighting the 'fatal imbalance' between global disease burden and drug development for some of the world most devastating illnesses, said Doctors Without Borders/M-decins Sans Fronti-res (MSF) and the Drugs for Neglected Diseases initiative (DNDi), in an analysis to be presented today at an international conference aimed at spurring medical innovations for these diseases.
A study conducted by researchers at Thomas Jefferson University, Philadelphia, and published Tuesday, July 27, 2004, in the journal Neurology, shows that Frova (frovatriptan), a triptan class migraine therapy with a long half life, significantly reduced the incidence of menstrual associated migraines (MAM) in women who took the medication preventively, in advance of anticipated onset of headache.
Researchers at University of California, San Diego School of Medicine have identified a control mechanism for an area of the brain that processes sensory and emotive information that humans experience as "disappointment."
› Verified 5 days ago
Dr. Thomas Derek Kowalik, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1200 Ne 48th Ave Ste 1100, Hillsboro, OR 97124 Phone: 503-844-8219 Fax: 503-844-8234 | |
Sarah L. Lampton, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 425 Se Baseline St, Hillsboro, OR 97123 Phone: 503-681-9676 Fax: 503-615-0434 | |
Bart Rask, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 349 Se 7th Ave, Hillsboro, OR 97123 Phone: 509-648-0803 Fax: 503-640-4313 | |
John A Voss, PA-C, MS Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2875 Ne Stucki Ave, Hillsboro, OR 97124 Phone: 503-813-2000 | |
Anton F Eilers, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 349 Se 7th Ave, Hillsboro, OR 97123 Phone: 503-648-0803 Fax: 503-640-4313 | |
Dr. John Milton Coletti Jr., M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 335 Se 8th Ave, Hillsboro, OR 97123 Phone: 503-681-1271 Fax: 503-648-1399 | |
Dr. David Alan Buuck, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1200 Ne 48th Ave, Ste 1100, Hillsboro, OR 97124 Phone: 503-844-8310 |